» Articles » PMID: 28389300

Asthma Control and Sputum Eosinophils: A Longitudinal Study in Daily Practice

Overview
Date 2017 Apr 9
PMID 28389300
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Longitudinal trials have suggested that asthma control may be influenced by fluctuations in eosinophilic inflammation. This association has however never been confirmed in daily practice.

Objective: To investigate the relationship between asthma control and sputum eosinophils in clinical practice.

Methods: A retrospective longitudinal study was conducted on 187 patients with asthma with at least 2 successful sputum inductions at our Asthma Clinic. Linear mixed models were used to assess the relationship between asthma control and individual changes in sputum eosinophils. Receiver-operating characteristic curves were constructed to define minimal important differences (MIDs) of sputum eosinophils associated with a change of at least 0.5 in Asthma Control Questionnaire (ACQ) score. Then, a validation cohort of 79 patients with asthma was recruited to reassess this relationship and the accuracy of the MID values.

Results: A multivariate analysis showed that asthma control was independently associated with individual fluctuations in sputum eosinophil count (P < .001). In patients with intermittent/persistently eosinophilic asthma, we calculated a minimal important decrease of 4.3% in the percentage of sputum eosinophils (area under the curve [AUC], 0.69; P < .001) or 3.4-fold (AUC, 0.65; P = .003) for a significant improvement in asthma control and a minimal important increase of 3.5% (AUC, 0.67; P = .004) or 1.8-fold (AUC, 0.63; P = .02) for a significant worsening in asthma control. The association between asthma control and sputum eosinophils and the accuracy of the MIDs of sputum eosinophils were confirmed in the validation cohort.

Conclusions: At the individual level, asthma control was associated with fluctuations in sputum eosinophil count over time.

Citing Articles

Eosinophil-Driven vs. Eosinophil-Associated Severe Asthma: Practical Implications for Target Treatment.

DAiuto V, Mormile I, Granata F, Romano A, Della Casa F, Mignogna G Int J Mol Sci. 2025; 26(4).

PMID: 40004192 PMC: 11855446. DOI: 10.3390/ijms26041729.


Total immunoglobulin E levels in induced sputum reflect asthma control status.

Chen W, Liu X, Yao X, Hao Y, Zhou Z, Wang C Clin Transl Allergy. 2025; 15(1):e70021.

PMID: 39757370 PMC: 11702434. DOI: 10.1002/clt2.70021.


Asthma control and sputum eosinophils in adult patients: a cross-sectional study in southern Brazil.

Barcellos V, Dos Santos V, Moreira M, Dalcin P Sci Rep. 2023; 13(1):21464.

PMID: 38052916 PMC: 10697938. DOI: 10.1038/s41598-023-48381-1.


Sputum induction and its diagnostic applications in inflammatory airway disorders: a review.

Goncalves B, Eze U Front Allergy. 2023; 4:1282782.

PMID: 37901763 PMC: 10600502. DOI: 10.3389/falgy.2023.1282782.


Upper airway disease diagnosis as a predictive biomarker of therapeutic response to biologics in severe asthma.

Cottin S, Doyen V, Pilette C Front Med (Lausanne). 2023; 10:1129300.

PMID: 37035303 PMC: 10073432. DOI: 10.3389/fmed.2023.1129300.